Clinical Significance of Plasma Leptin and Its Receptors mRNA Expression in Craniopharyngiomas: A Prospective Study
- PMID: 37509115
- PMCID: PMC10377231
- DOI: 10.3390/biom13071078
Clinical Significance of Plasma Leptin and Its Receptors mRNA Expression in Craniopharyngiomas: A Prospective Study
Abstract
Craniopharyngioma (CP) is a benign tumor with a high rate of obesity and frequent recurrence. Moreover, the role of leptin/leptin receptors axis in obesity and the prognosis of CP is still unknown. Plasma leptin concentration and mRNA expression of leptin receptors were assessed in patients with CP. Moreover, the association between leptin/leptin receptors axis, weight-related outcomes, and progression-free survival (PFS) were explored in CP patients. Leptin receptors overexpressed in CP tumor tissue were compared to normal brain tissue (p < 0.05); compared to healthy controls, the concentration of leptin was elevated in CP with or without matched age, sex, and body mass index (BMI) (p < 0.05). The high plasma leptin level was an independent risk predictor for significant weight gain (adjusted odds ratio (aOR) = 2.29, and p = 0.030) and new-onset obesity (aOR = 6.64, and p = 0.016). High plasma leptin level (adjusted hazard ratio (aHR) = 3.74, and p = 0.011) and leptin receptor (LEPR) mRNA expression (aHR = 3.12, and p = 0.045) were independent risk factors for poor PFS in CP. Inappropriately elevated leptin relative to BMI and its failure to inhibit further weight gain indicate the existence of leptin resistance in patients with CP. Leptin and LEPR were independent predictors for PFS of patients with CP. The leptin/leptin receptors axis may be a potential therapeutic target for obesity in patients with CP.
Keywords: craniopharyngioma; leptin; leptin resistance; obesity; progression-free survival.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.
Figures
Similar articles
-
The clinical significance of inflammatory mediators in predicting obesity and progression-free survival in patients with adult-onset Craniopharyngioma.BMC Cancer. 2024 Jul 4;24(1):799. doi: 10.1186/s12885-024-12548-4. BMC Cancer. 2024. PMID: 38965454 Free PMC article.
-
Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.Cancer. 2017 Sep 15;123(18):3617-3627. doi: 10.1002/cncr.30707. Epub 2017 May 23. Cancer. 2017. PMID: 28543182 Free PMC article.
-
Polymorphisms in the leptin (rs7799039) gene are associated with an increased risk of excessive gestational weight gain but not with leptin concentration during pregnancy.Nutr Res. 2017 Nov;47:53-62. doi: 10.1016/j.nutres.2017.09.003. Epub 2017 Sep 15. Nutr Res. 2017. PMID: 29241578
-
Role of Leptin Deficiency, Inefficiency, and Leptin Receptors in Obesity.Biochem Genet. 2016 Oct;54(5):565-72. doi: 10.1007/s10528-016-9751-z. Epub 2016 Jun 16. Biochem Genet. 2016. PMID: 27313173 Review.
-
Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications.Pharmacogenomics. 2011 Jul;12(7):999-1016. doi: 10.2217/pgs.11.45. Pharmacogenomics. 2011. PMID: 21787190 Free PMC article. Review.
Cited by
-
The clinical significance of inflammatory mediators in predicting obesity and progression-free survival in patients with adult-onset Craniopharyngioma.BMC Cancer. 2024 Jul 4;24(1):799. doi: 10.1186/s12885-024-12548-4. BMC Cancer. 2024. PMID: 38965454 Free PMC article.
References
-
- Müller H.L., Emser A., Faldum A., Bruhnken G., Etavard-Gorris N., Gebhardt U., Oeverink R., Kolb R., Sörensen N. Longitudinal Study on Growth and Body Mass Index before and after Diagnosis of Childhood Craniopharyngioma. J. Clin. Endocrinol. Metab. 2004;89:3298–3305. doi: 10.1210/jc.2003-031751. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous